|
38 Companies |
|
50 Products |
|
50 Products |
|
51 Mechanisms of Action |
|
3 Trials |
|
1810 News |
|
| «12...1415161718192021222324...3132» |
- Enrollment open: Computer MI for Tobacco Quitline Engagement in Smokers Living With HIV (clinicaltrials.gov) - Mar 2, 2014
P=N/A, N=100, Recruiting, Sponsor: Butler Hospital
Not yet recruiting --> Recruiting
- Trial withdrawal: An Evidence Based Smoking Cessation Program for Persons Living With HIV/AIDS (Project Legacy) (clinicaltrials.gov) - Feb 26, 2014
P=N/A, N=0, Withdrawn, Sponsor: M.D. Anderson Cancer Center
Not yet recruiting --> Recruiting Not yet recruiting --> Withdrawn
- Enrollment change: An Evidence Based Smoking Cessation Program for Persons Living With HIV/AIDS (Project Legacy) (clinicaltrials.gov) - Feb 26, 2014
P=N/A, N=0, Withdrawn, Sponsor: M.D. Anderson Cancer Center
Not yet recruiting --> Withdrawn N=1000 --> 0
- Biomarker, Enrollment change: NOnourisson: Is the Exhaled Nitric Oxide in Infants a Predictive Marker of Asthma ? (clinicaltrials.gov) - Feb 25, 2014
P=N/A, N=86, Completed, Sponsor: Assistance Publique - H
N=1000 --> 0 N=264 --> 86
- Biomarker, Trial completion: NOnourisson: Is the Exhaled Nitric Oxide in Infants a Predictive Marker of Asthma ? (clinicaltrials.gov) - Feb 25, 2014
P=N/A, N=86, Completed, Sponsor: Assistance Publique - H
N=264 --> 86 Active, not recruiting --> Completed
- Adherence: mSMART: Mobile App Based Personalized Solutions and Tools for Medication Adherence of Rx Pills (clinicaltrials.gov) - Feb 24, 2014
P=N/A, N=9, Recruiting, Sponsor: Duke University
- Enrollment change: MassCONECT (Massachusetts Community Networks to Eliminate Cancer Disparities Through Education) 4 Kids: Promoting Smoke-free Homes (clinicaltrials.gov) - Feb 23, 2014
P=N/A, N=138, Completed, Sponsor: Harvard School of Public Health
Active, not recruiting --> Completed N=350 --> 138
- Enrollment closed: AsuRiesgo: Cardiovascular Risk Factors in an Ambulatory Urban Patient Population (clinicaltrials.gov) - Feb 23, 2014
P=N/A, N=7000, Active, not recruiting, Sponsor: University of Heidelberg
N=350 --> 138 Recruiting --> Active, not recruiting
- Trial completion: MassCONECT (Massachusetts Community Networks to Eliminate Cancer Disparities Through Education) 4 Kids: Promoting Smoke-free Homes (clinicaltrials.gov) - Feb 23, 2014
P=N/A, N=138, Completed, Sponsor: Harvard School of Public Health
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Financial Incentives for Smoking Cessation (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=878, Completed, Sponsor: University of Pennsylvania
Active, not recruiting --> Completed Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: GN Tobacco Use Survey (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=6000, Completed, Sponsor: NICHD Global Network for Women's and Children's Health
Recruiting --> Completed Recruiting --> Completed
- ||||||| rosiglitazone / Generic mfg.
Trial completion: Rosiglitazone Versus Theophylline in Asthmatic Smokers (clinicaltrials.gov) - Feb 22, 2014
P2/3, N=79, Completed, Sponsor: University of Glasgow
Recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Quitlink : A Leveraging Solution to Tobacco Counseling (clinicaltrials.gov) - Feb 22, 2014
P3, N=3200, Completed, Sponsor: Virginia Ambulatory Care Outcomes Research Network
No longer recruiting --> Completed Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Non-Nicotine Agents for Smoking Cessation (clinicaltrials.gov) - Feb 22, 2014
P3, N=0, Completed, Sponsor: Department of Veterans Affairs
Recruiting --> Completed Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Improving Smoking Cessation Outcomes in Heavy Drinkers - 1 (clinicaltrials.gov) - Feb 22, 2014
P2, N=236, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting --> Completed Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Oxidative Stress and Vitamin E Requirements (clinicaltrials.gov) - Feb 22, 2014
P2, N=99, Completed, Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Obesity Prevention After Smoking Cessation in Menopause (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=100, Completed, Sponsor: National Institute on Aging (NIA)
No longer recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Nevada Environmental Tobacco Smoke and Health Study (clinicaltrials.gov) - Feb 22, 2014
P3, N=375, Completed, Sponsor: National Institute of Environmental Health Sciences (NIEHS)
No longer recruiting --> Completed Recruiting --> Completed
- | bupropion / Generic mfg.
Trial completion: Bupropion as a Smoking Cessation Aid in Alcoholics (clinicaltrials.gov) - Feb 22, 2014
P4, N=200, Completed, Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Theory-Based Interventions for Smoking and Obesity (Challenge) Trial (clinicaltrials.gov) - Feb 22, 2014
P3, N=1778, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
No longer recruiting --> Completed No longer recruiting --> Completed
- | naltrexone / Generic mfg.
Trial completion: Naltrexone and Patch for Smokers (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=0, Completed, Sponsor: Department of Veterans Affairs
No longer recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Combinations of Pharmacologic Smoking Cessation Treatments (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: Department of Veterans Affairs
No longer recruiting --> Completed No longer recruiting --> Completed
- ||||||| fluoxetine / Generic mfg.
Trial completion: Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers (clinicaltrials.gov) - Feb 19, 2014
P3, N=247, Completed, Sponsor: Department of Veterans Affairs
No longer recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Treatment to Quit Smoking (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Department of Veterans Affairs
No longer recruiting --> Completed No longer recruiting --> Completed
- | oltipraz (PMK-N01GI1) / Canopus BioPharma, Pharmaking
Trial completion: Oltipraz in the Prevention of Lung Cancer in People Who Smoke (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: Northwestern University
No longer recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Behavioral Counseling for Alcohol Dependent Smokers (Nicotine Patch) (clinicaltrials.gov) - Feb 19, 2014
P4, N=144, Completed, Sponsor: Mayo Clinic
Active, not recruiting --> Completed No longer recruiting --> Completed
- | naltrexone / Generic mfg.
Trial completion: Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (Naltrexone/Nicotine Patch) (clinicaltrials.gov) - Feb 19, 2014
P4, N=200, Completed, Sponsor: The University of Texas Health Science Center, Houston
No longer recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Timing of Smoking Intervention in Alcohol Treatment (Nicotine Patch) (clinicaltrials.gov) - Feb 19, 2014
P4, N=500, Completed, Sponsor: Minneapolis Veterans Affairs Medical Center
No longer recruiting --> Completed No longer recruiting --> Completed
- methadone / Generic mfg.
Trial completion: Incentive-based Smoking Cessation for Methadone Patients (clinicaltrials.gov) - Feb 19, 2014
P2, N=170, Completed, Sponsor: Fletcher Allen Health Care
No longer recruiting --> Completed Recruiting --> Completed
- || Enrollment change: Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 (THS 2.2) (clinicaltrials.gov) - Feb 18, 2014
P=N/A, N=63, Completed, Sponsor: Philip Morris Products S.A.
Recruiting --> Completed N=90 --> 63
- ||| Trial completion: Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 (THS 2.2) (clinicaltrials.gov) - Feb 18, 2014
P=N/A, N=63, Completed, Sponsor: Philip Morris Products S.A.
N=90 --> 63 Recruiting --> Completed
- Enrollment closed: Developing a Smoking Cessation Intervention for Methadone Maintained Smokers (clinicaltrials.gov) - Feb 13, 2014
P1, N=118, Active, not recruiting, Sponsor: University of Medicine and Dentistry of New Jersey
Recruiting --> Completed Recruiting --> Active, not recruiting
- Chantix (varenicline) / Pfizer
Enrollment change: Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix) (clinicaltrials.gov) - Feb 12, 2014
P=N/A, N=30, Active, not recruiting, Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting --> Active, not recruiting N=100 --> 30
- Enrollment change: Internet-Administered Smoking Cessation Treatment for Overweight and Obese Smokers (clinicaltrials.gov) - Feb 11, 2014
P=N/A, N=54, Completed, Sponsor: Yale University
N=100 --> 30 N=84 --> 54
- Trial completion: Internet-Administered Smoking Cessation Treatment for Overweight and Obese Smokers (clinicaltrials.gov) - Feb 11, 2014
P=N/A, N=54, Completed, Sponsor: Yale University
N=84 --> 54 Recruiting --> Completed
- ||| Biomarker, Trial completion, HEOR: Switching From Usual Brand Cigarettes to a Tobacco-heating Cigarette or Snus (clinicaltrials.gov) - Feb 10, 2014
P=N/A, N=163, Completed, Sponsor: R.J. Reynolds Tobacco Company
Recruiting --> Completed Not yet recruiting --> Completed
- Trial termination: Insulin Resistance in Smokers Undergoing Smoking Cessation (clinicaltrials.gov) - Feb 6, 2014
P=N/A, N=103, Terminated, Sponsor: Charles Drew University of Medicine and Science
Not yet recruiting --> Completed Recruiting --> Terminated; Funding expired
- Enrollment change: Insulin Resistance in Smokers Undergoing Smoking Cessation (clinicaltrials.gov) - Feb 6, 2014
P=N/A, N=103, Terminated, Sponsor: Charles Drew University of Medicine and Science
Recruiting --> Terminated; Funding expired N=80 --> 103
- gemfibrozil / Generic mfg.
Trial initiation date: Initial Screening of Gemfibrozil as a Novel Treatment for Tobacco Addiction (clinicaltrials.gov) - Feb 5, 2014
P2, N=40, Recruiting, Sponsor: Centre for Addiction and Mental Health
N=80 --> 103 Initiation date: Oct 2013 --> Feb 2014
- Enrollment closed: A Test of Short and Long Term Naturalistic Outcomes of Smokers Who Sample Smokeless Tobacco (clinicaltrials.gov) - Feb 5, 2014
P=N/A, N=1400, Active, not recruiting, Sponsor: Medical University of South Carolina
Initiation date: Oct 2013 --> Feb 2014 Enrolling by invitation --> Active, not recruiting
- Trial completion: CBT-HT: Cognitive-Behavioral Therapy and Hypnotherapy for Smoking Cessation (clinicaltrials.gov) - Feb 2, 2014
P=N/A, N=360, Completed, Sponsor: University Hospital Tuebingen
Enrolling by invitation --> Active, not recruiting Active, not recruiting --> Completed
- Trial completion: Examining a Text Message Intervention for Smoking Cessation (clinicaltrials.gov) - Jan 30, 2014
P=N/A, N=84, Completed, Sponsor: The Miriam Hospital
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment closed: Project Quit: Positive vs. Negative Offers of an Online Stop Smoking Program (clinicaltrials.gov) - Jan 29, 2014
P=N/A, N=1500, Active, not recruiting, Sponsor: University of Michigan
Recruiting --> Completed Enrolling by invitation --> Active, not recruiting
- Chantix (varenicline) / Pfizer
Enrollment closed: Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation (clinicaltrials.gov) - Jan 28, 2014
P1/2, N=200, Active, not recruiting, Sponsor: Johns Hopkins University
Enrolling by invitation --> Active, not recruiting Recruiting --> Active, not recruiting
- FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Enrollment change: Effects of Sulforaphane (SFN) on Immune Response to Live Attenuated Influenza Virus in Smokers and Nonsmokers (clinicaltrials.gov) - Jan 27, 2014
P=N/A, N=51, Completed, Sponsor: University of North Carolina, Chapel Hill
Recruiting --> Active, not recruiting N=84 --> 51
- FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Trial completion: Effects of Sulforaphane (SFN) on Immune Response to Live Attenuated Influenza Virus in Smokers and Nonsmokers (clinicaltrials.gov) - Jan 27, 2014
P=N/A, N=51, Completed, Sponsor: University of North Carolina, Chapel Hill
N=84 --> 51 Recruiting --> Completed
- Enrollment closed: Web-based Smoking Cessation Intervention: Transition From Inpatient to Outpatient (clinicaltrials.gov) - Jan 26, 2014
P4, N=1488, Active, not recruiting, Sponsor: University of Alabama at Birmingham
Recruiting --> Completed Recruiting --> Active, not recruiting
- | Chantix (varenicline) / Pfizer
Enrollment closed: Smoking Cessation for American Indians (clinicaltrials.gov) - Jan 26, 2014
P3, N=448, Active, not recruiting, Sponsor: Won Choi, PhD, MPH
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | Belviq (lorcaserin) / Eisai
New P2 trial: A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation (clinicaltrials.gov) - Jan 22, 2014
P2, N=600, Recruiting, Sponsor: Arena Pharmaceuticals
- Enrollment open: Computer-Facilitated 5A's for Smoking Cessation in Primary Care (clinicaltrials.gov) - Jan 22, 2014
P=N/A, N=1500, Recruiting, Sponsor: University of California, San Francisco
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting